`
`
`Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`
`IN THE UNITED STATES PATENT TRIAL AND APPEAL BOARD
`
`U.S. Patent 7,958,024
`
`
`
`U.S. Class: 705
`
`Group Art Unit: 3691
`
`Confirmation No. 7510
`
`Petition filed: August 29, 2013
`
`
`FILED ELECTRONICALLY
`PER 37 C.F.R. § 42.6(B)(1)
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`
`
`
`
`
`In re CBM Review of:
`
`
`
`Issued: June 7, 2011
`
`Inventor: David Chao et al.
`
`Application No. 09/810,012
`
`Filed: March 15, 2001
`
`For: METHOD AND APPARATUS
`FOR PROCESSING SALES
`TRANSACTION DATA
`
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S.P.T.O.
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`PETITION FOR COVERED BUSINESS METHOD PATENT
`REVIEW UNDER 35 U.S.C. § 321 AND §18 OF THE
`LEAHY-SMITH AMERICA INVENTS ACT
`
`Pursuant to 35 U.S.C. § 321 and § 18 of the Leahy-Smith America Invents
`
`Act (“AIA”) and pursuant to 37 C.F.R. § 42.300 et seq., the undersigned hereby
`
`requests covered business method (“CBM”) patent review of claims 1, 2, and 35-
`
`
`
`i
`
`DOCSLA#112133
`
`
`
`
`
`47 of U.S. Patent 7,958,024 (“the ‘024 patent,” attached as Petition Exhibit 1001),
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`which issued to David Chao et al. on June 7, 2011.
`
`An electronic payment in the amount of $30,000.00 for the covered business
`
`method review fee specified by 37 C.F.R. § 42.15(b)(1) is being paid at the time of
`
`filing this petition, charged to deposit account No. 041073.
`
`
`
`
`
`ii
`
`DOCSLA#112133
`
`
`
`
`
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`TABLE OF CONTENTS
`
`Page No.
`
`PRELIMINARY STATEMENT ..................................................................... 1
`I.
`II. GROUNDS FOR STANDING ........................................................................ 4
`A. ..... Petitioner has Been Sued for Infringement of the ‘024 Patent and
`is Not Estopped ..................................................................................... 4
`B. ..... At Least One Challenged Claim is Unpatentable ................................. 4
`C. ..... The ‘024 Patent is a CBM Patent .......................................................... 5
`1. ...... Claims 1, 2, and 35-47 are Directed to Financial Products or
`Services ....................................................................................... 5
`2. ...... Claims 1, 2, and 35-47 are Not Directed to a “Technological
`Invention” .................................................................................... 8
`III. STATEMENT OF PRECISE RELIEF REQUESTED FOR EACH CLAIM
`CHALLENGED ............................................................................................ 17
`A. ..... Claims for which Review is Requested .............................................. 17
`B. ..... Statutory Grounds of Challenge .......................................................... 17
`IV. CLAIM CONSTRUCTION .......................................................................... 17
`A. ..... Broadest Reasonable Interpretation .................................................... 18
`B. ..... Support for Petitioner’s Broadest Reasonable Interpretation ............. 22
`1. ...... “Distributer Management System” ........................................... 22
`2. ...... “Regulatory Conditions Applicable to Said Sales” /
`“Regulatory Conditions Associated with Said Sales” .............. 24
`3. ...... “Executing a Payment Process” / “Execute a Payment
`Process” ..................................................................................... 26
`
`
`
`iii
`
`DOCSLA#112133
`
`
`
`
`
`
`V.
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`4. ...... “Generating a Selling Agreement” / “Generate a Selling
`Agreement” ............................................................................... 27
`5. ...... Means-Plus-Function Claim Terms .......................................... 28
`CLAIMS 1, 2, AND 35-47 OF THE ‘024 PATENT ARE DIRECTED TO
`NON-PATENTABLE SUBJECT MATTER ................................................ 29
`A. ..... Inventions Covering Abstract Ideas are Not Eligible for Patent
`Protections, Regardless of their Form ................................................. 29
`B. ..... Claim 1 of the ‘024 Patent is Directed to an Abstract Idea ................. 31
`1. ...... Any Computer System Used to Implement the Claimed
`Method is No More than a General Purpose Computer ........... 36
`2. ...... Computing Compensation for Sales Representatives that
`Conforms with a Set of Regulatory Conditions Can Be
`Accomplished by Hand ............................................................. 40
`3. ...... Claim 1 Fails the Machine-or-Transformation Test ................. 44
`C. ..... Claim 40 of the ‘024 Patent is Directed to an Abstract Idea............... 49
`D. ..... Claim 42 of the ‘024 Patent is Directed to an Abstract Idea............... 52
`E. ...... Claim 45 of the ‘024 Patent is Directed to an Abstract Idea............... 54
`F. ...... Dependent Claims 2, 35-39, 41, 43, 44, 46, and 47 also Define
`Abstract Ideas that Fail to Tie Down the Claimed Abstract Idea ....... 57
`1. ...... Dependent Claims 2, 41, 44, and 47 Add Nothing More
`Than Insignificant Post-Solution Activity to the Abstract
`Idea of Independent Claims 1, 40, 42, and 45. ......................... 57
`2. ...... The Generating Reports Limitations of Dependent Claims
`35/38 and 36/ 39 are Also Insignificant Post-Solution
`Activity ...................................................................................... 60
`3. ...... Dependent Claims 37, 43, and 46 Merely Limit the Claims
`to a Particular Species or Field of Use ...................................... 61
`
`
`
`iv
`
`DOCSLA#112133
`
`
`
`
`
`VI. CONCLUSION .............................................................................................. 63
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`
`
`v
`
`DOCSLA#112133
`
`
`
`
`
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`LIST OF EXHIBITS
`
`Petition Exhibit 1001: U.S. Patent No. 7,958,024
`
`Petition Exhibit 1002: U.S. Patent No. 7,958,024 File History.
`
`Petition Exhibit 1003: Complaint, Versata Software, Inc. v. Callidus Software
`Inc. Litigation, Case No. 1:12-cv-00931-SLR (D. Del.
`July 19, 2012), D.N. 1
`
`Petition Exhibit 1004: Decision to Institute in SAP v. Versata, CBM2012-
`00001, Paper No. 36 (PTAB Jan. 9, 2013)
`
`Petition Exhibit 1005: United States Patent and Trademark Office –
`Classification Definitions, Class 705
`
`Petition Exhibit 1006: Transitional Program for Covered Business Method
`Patents—Definitions of Covered Business Method Patent
`and Technological Invention, 77 Fed. Reg. 48734 (Aug.
`14, 2012)
`
`Petition Exhibit 1007:
`
`Patent Owner’s Preliminary Response in SAP v. Versata,
`CBM2012-00001, Paper No. 29 (PTAB Nov. 30, 2012)
`
`Petition Exhibit 1008: Official Patent Trial Practice Guide, 77 Fed. Reg. 48756
`(Aug. 14, 2012)
`
`Petition Exhibit 1009:
`
`Final Written Decision in SAP v. Versata, CBM2012-
`00001, Paper No. 70 (PTAB June 11, 2013).
`
`Petition Exhibit 1010: Changes to Implement Inter Partes Review Proceedings,
`Post-Grant Review Proceedings, and Transitional
`Program for Covered Business Method Patents, 77 Fed.
`Reg. 48680 (Aug. 14, 2012)
`
`Petition Exhibit 1011: Declaration of Joseph E. DeHaven in Support of Petition
`for Covered Business Method Patent Review of U.S.
`Patent No. 7,904,326
`
`
`
`vi
`
`DOCSLA#112133
`
`
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`
`
`Petition Exhibit 1012: Declaration of Janis McGuffey in Support of Petition for
`Covered Business Method Patent Review of U.S. Patent
`No. 7,904,326
`
`
`
`
`
`vii
`
`DOCSLA#112133
`
`
`
`Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`
`
`
`
`I.
`
`
`
`PRELIMINARY STATEMENT
`
`The ‘024 patent claims nothing more than the abstract idea of compensating
`
`sales representatives for their sales transactions if they conform to regulatory
`
`conditions. But ensuring sales representatives conform to regulatory conditions
`
`before compensating them has been done in the absence of a “computer system”
`
`for decades either in the human mind or by hand with pencil and paper. Indeed,
`
`this has been a pre-requisite to receiving compensation in the insurance and
`
`financial services industries for many years. And for good reason — compliance
`
`with regulatory constraints was and is required by law. Exh. 1001, 1:34-36
`
`(“There are regulatory constraints on the sales force in that all distributors who sell
`
`products must be licensed and appointed, or authorized, to sell those products.”);
`
`3:24-33 (“Credential management is a critical issue for many firms . . . This need is
`
`made more acute by constantly changing government rules and regulations, as well
`
`as by different regulations imposed by the different jurisdictions in which a firm
`
`operates.”)
`
`Claim 1 is representative of each of the four independent claims of the ‘024
`
`patent:
`
`
`
`1
`
`DOCSLA#112133
`
`
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`
`
`
`1. A method for processing sales transaction data comprising:
`using a distributer management system to perform:
`capturing transaction data associated with sales
`performed by a plurality of sales
`representatives;
`determining if said sales representatives associated
`with said transaction data are in conformity
`with a set of regulatory conditions
`applicable to said sales;
`computing a plurality of compensation amounts
`based on said sale transactions data and said
`set of regulatory conditions; and
`executing a payment process to compensate said
`plurality of sales representatives for said
`sales in accordance with said compensation
`amounts. Id., 26:19-32.
`The “capturing,” “determining,” “computing,” and “executing” of data do not
`
`meaningfully limit the abstract idea. The recited capturing step merely collects
`
`data associated with sales transactions to be used in the determining and computing
`
`steps. The determining and computing steps are nothing more than the abstract
`
`idea of compensating sales representatives for their sales transactions if they
`
`conform to regulatory conditions. The final step, executing a payment process, is
`
`nothing more than distributing payment to the sales representatives. These are
`
`steps that can, and have been, historically done by hand, and any general purpose
`
`
`
`2
`
`DOCSLA#112133
`
`
`
`
`
`computer involvement in claim 1 is merely incidental to the abstract idea. Claim 1
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`is not tied to a particular machine and does not transform an article.
`
`The other three independent claims recite very similar limitations but rewrite
`
`the method of claim 1 in one of several software forms: a computer readable
`
`medium (claim 42), a computer with code in its memory (claim 45), and a
`
`processing system employing certain software engines and modules (claim 40).
`
`Here, the claimed methods do nothing more than add a general purpose
`
`computer to a decades-old method of doing business, i.e., the recited computer
`
`media and computer systems use conventional and routine computer processing
`
`functionality to implement an abstract idea. General purpose computers are
`
`conventional, widely-used tools to manage and process data in the information age.
`
`Neither the recited “distributor management system,” “system,” “computer
`
`readable medium,” nor “system comprising: a processor; and a memory” in the
`
`independent claims provide any meaningful limit on the patent’s coverage of the
`
`abstract idea. They are not tied to any particular machine nor do they transform or
`
`reduce any article into a different state or thing. Accordingly, independent claims
`
`1, 40, 42, and 45 of the ‘024 patent are patent-ineligible under 35 U.S.C. § 101
`
`because they are directed to an abstract idea. Because dependent claims 2, 35-39,
`
`41, 43, 44, 46, and 47 do not add any meaningful limitations to the independent
`
`
`
`3
`
`DOCSLA#112133
`
`
`
`
`
`claims of the ‘024 patent, they fail to tie down the abstract idea of the claimed
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`subject matter and are also unpatentable under 35 U.S.C. § 101.
`
`II. GROUNDS FOR STANDING
`A.
`Petitioner has Been Sued for Infringement of the ‘024 Patent and
`is Not Estopped
`
`Petitioner has standing to file this petition because Petitioner has been sued
`
`for infringement of the ‘024 Patent in Versata Software, Inc. v. Callidus Software,
`
`Inc., No. 1:12-cv-931-SLR (D. Del.). Exh. 1003; AIA, § 18(a)(1)(B); 37 C.F.R.
`
`42.302(a). Versata Software, Inc. and Versata Development Group, Inc.
`
`(collectively “Versata” or “Patent Owner”) purport to hold all right, title, and
`
`interest in the ‘024 Patent. Id., ¶ 8.
`
`Petitioner is not estopped from challenging the claims on the grounds
`
`identified in the petition.1 37 C.F.R. § 42.302(b). Petitioner has not been party to
`
`any other post-grant review of the challenged claims.
`
`B. At Least One Challenged Claim is Unpatentable
`As detailed further below, claims 1, 2, and 35-47 of the ‘024 Patent are
`
`unpatentable under 35 U.S.C. § 101 and it is “more likely than not that at least one
`
`of the claims challenged” of the ‘024 Patent is unpatentable. 35 U.S.C. § 324(a).
`
`
`1 The Board previously held that § 101 is a permissible grounds for challenging
`claims in a CBM review. Exh. 1004, at 32-36.
`
`
`
`4
`
`DOCSLA#112133
`
`
`
`
`
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`C. The ‘024 Patent is a CBM Patent
`A “covered business method patent” (“CBM patent”) is defined as “a patent
`
`that claims a method or corresponding apparatus for performing data processing or
`
`other operation used in the practice, administration, or management of a financial
`
`product or service, except that the term does not include patents for technological
`
`inventions.” AIA, § 18(d)(1); see also 37 C.F.R. § 42.301(a). “The term financial
`
`is an adjective that simply means relating to monetary matters.” Exh. 1004, at 23.
`
`The ‘024 Patent easily meets the definition of a CBM patent.
`
`1.
`
`Claims 1, 2, and 35-47 are Directed to Financial Products or
`Services
`
`The claims and specification show that the claimed methods of the ‘024
`
`patent are directed to financial products or services, i.e. monetary matters. Claim 1
`
`is directed to computing compensation for sales representatives that conform to a
`
`set of regulatory conditions. Exh. 1001, 26:19-32. The process of calculating
`
`compensation amounts and paying sales representatives clearly relates to monetary
`
`matters.
`
`Furthermore, the claimed subject matter is obviously directed to the financial
`
`industry, and its products and services. The first line of the Abstract states: “A
`
`system provides a way to manage agreements that institutions such as financial
`
`services companies have with distributors who sell their products.” Id., Abstract
`
`
`
`5
`
`DOCSLA#112133
`
`
`
`
`
`(emphasis added); see also id., 3:1-4 (“Another need of firms in financial services
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`is an ability to manages sales producer payment accounts”). Similarly, the
`
`Summary of the Invention states that “systems embodying the invention provide a
`
`way to manage the agreements that financial services companies have with the
`
`distributors who sell their products.” Id., 4:47-50 (emphasis added). In total, the
`
`‘024 patent states “financial services” or “financial products” no less than 38 times
`
`throughout the disclosure. See, e.g., Id., 14:27-34 (“provider of financial
`
`products”), 1:23 (“financial services providers”), 4:20 (“a product, which may
`
`include financial services”), 6:47 (“financial services institutions”). Financial
`
`services and insurance companies paying sales representatives for their sales of
`
`financial products, and checking their credentials to ensure that they are eligible for
`
`compensation is squarely within the “practice, administration, or management of a
`
`financial product or service.” AIA, § 18(d)(1). During prosecution, the applicant
`
`confirmed the connection to financial products and services. Applicant attempted
`
`to distinguish prior art references on the grounds that the prior art “is directed
`
`towards ensuring compliance with regulations of products and not with ‘sales
`
`representatives’ conformity with regulatory conditions. . . . ‘Products’ can be the
`
`subject of a sale. Clearly, ‘sales representatives,’ are not the subject of a sale.”
`
`Exh. 1002, 3/16/2009 Response to Non-Final Office Action at 14.
`
`
`
`6
`
`DOCSLA#112133
`
`
`
`
`
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`The ‘024 Patent is classified in both 705/35 and 705/40. Exh. 1001, INID
`
`Code 52. Class 705 is entitled “Data Processing: Financial, Business Practice,
`
`Management, or Cost/Price Determination.” Exh. 1005 at 1. While classification
`
`in class 705 is not determinative, it suggests that the claims of the ‘024 Patent are
`
`directed to financial products and services. Exh. 1006 at 48739 (“patents subject to
`
`covered business method patent review are anticipated to be typically classifiable
`
`in class 705”).
`
`Patent Owner Versata, in its Preliminary Response to SAP America, Inc.’s
`
`Petition For Post-Grant Review in CBM2012-00001, cited several sources that it
`
`argued provide a definition for “financial product” and “financial service,” many
`
`of which apply the claims of the ‘024 Patent. For “financial product” its various
`
`definitions included “an insurance product,” “insurance contracts,” and all manner
`
`of financial instruments, including bank deposits, credit lines, bonds, mortgages,
`
`leases, and so on. Exh. 1007, at 33, 35. Versata defined “financial services” as “a
`
`business activity whose primary purpose is the development or provision of
`
`financial products, or facilitating the use of financial products.” Id., at 35
`
`(emphasis added). As discussed above, the specification of the ‘024 Patent states
`
`that “the invention” relates to systems to “manage the agreements that financial
`
`services companies have with the distributors who sell their products.” Exh. 1001,
`
`4:47-50. The ‘024 patent also discloses that “organizations such as life insurances
`
`
`
`7
`
`DOCSLA#112133
`
`
`
`
`
`companies may utilize embodiments of the invention to manage the sale and
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`distribution of life insurance plans in a way that coincides with the regulatory
`
`constraints of government organizations.” Id., 6:16-19; see also id., 7:21-23
`
`(“Each transaction represents a physical sales transaction, such as distributor
`
`selling a life insurance policy.”). Because these examples relate to the provision of
`
`financial products, under Patent Owner Versata’s own admitted definitions, the
`
`‘024 Patent claims a method used in the “practice, administration, or management
`
`of a financial product or service.”
`
`Thus, the ‘024 Patent meets the USPTO’s definition of a CBM patent.
`
`2.
`
`Claims 1, 2, and 35-47 are Not Directed to a “Technological
`Invention”
`A CBM patent does not cover “patents for technological inventions.” AIA,
`
`§ 18(d)(1). A technological invention exists only where “the claimed subject
`
`matter as a whole recites a technological feature that is novel and unobvious over
`
`the prior art; and solves a technical problem using a technical solution.” 37 C.F.R.
`
`42.301(b) (emphasis added). The claim must meet both prongs of the definition
`
`for the “technological invention” exception to apply. See Exh. 1006, at 48735
`
`(quoting statement of Sen. Coburn, 157 Cong. Rec. S5428 (daily ed. Sept. 8,
`
`2011)). The determination of whether a patent is a technological invention is
`
`based on the invention as claimed. Id., at 48736. To institute CBM review, it is
`
`
`
`8
`
`DOCSLA#112133
`
`
`
`
`
`only necessary that one claim of the ‘024 Patent is directed to a CBM that is not a
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`technological invention. Id., at 48736.
`
`Here, the ‘024 Patent claims fail both prongs and, thus, they are not directed
`
`to a technological invention.
`
`i.
`
`Any Allegedly Novel and Unobvious Features of the
`‘024 Patent are Not Technological
`
`The ‘‘024 patent does not recite a technological feature that is novel and
`
`unobvious over the prior art. The USPTO provides guidance as to claim drafting
`
`techniques that would not typically render a patent a technological invention under
`
`37 C.F.R. 42.301(b):
`
`(a) Mere recitation of known technologies, such as
`computer hardware, communication or computer
`networks, software, memory, computer readable storage
`medium, scanners, display devices or databases, or
`specialized machines, such as an ATM or point of sale
`device.
`
`(b) Reciting the use of known prior art technology to
`accomplish a process or method, even if that process or
`method is novel and non-obvious.
`
`(c) Combining prior art structures to achieve the normal,
`expected, or predictable result of that combination.
`
`
`
`9
`
`DOCSLA#112133
`
`
`
`
`
`Exh. 1008, at 48763-64. The only vaguely technological feature recited in claim 1
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`is “using a distributor management system.” Exh. 26:21. This is a mere recitation
`
`of a known technology, i.e. software, to accomplish the recited method, falling
`
`squarely into those inadequate claim drafting techniques. The ‘024 specification
`
`makes plain that a distributor management system is simply a collection of
`
`software applications that perform the recited method steps. Ex. 1001, 6:25-27
`
`(“[T]he system referred to hereinafter as Distributor Management System Suite
`
`(DMSS) comprises a suite of applications ….”). The ‘024 patent does not assert
`
`that the use of software to manage distributers is anything other than prior art. See,
`
`e.g., Id., 2:26-30 (“In the prior art, the creation and distribution of incentive plans
`
`is a slow process that is prone to error. It can take months to implement a new
`
`compensation plan, and dependencies on computer software can frustrate sales
`
`managers who want to make even simple changes.” (emphasis added)). The
`
`Background section of the ‘024 patent essentially concedes that the use of software
`
`to manage distributers was known to be required in the prior art. Id., 4:11-13
`
`(“Computer software is necessary to implement the solution to these problems and
`
`fulfill the perceived needs just described.” (emphasis added)). Software written to
`
`run on a general purpose computer system was well-known in the prior art, as was
`
`capturing data, checking data for conformity with conditions, and computing
`
`amounts from sets of data and conditions.
`
`
`
`10
`
`DOCSLA#112133
`
`
`
`
`
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`According to the applicant, the claimed subject matter can be implemented
`
`without requiring any specific technology. The applicant stated broadly that
`
`“numerous specific details are set forth in order to provide a more thorough
`
`understanding of the present invention,” but “the present invention may be
`
`practiced without these specific details.” Id., 5:65-6:3. While the specification
`
`notes that the “invention relates to the field of computer technology,” Exh. 1001,
`
`1:6, it fails to disclose any particular computer system, or even a general purpose
`
`computer. See generally, id., Figs. 1-7. Likewise, the specification discloses
`
`“computer software” and “implemented on a computer,” but only as a passing
`
`reference. Id., 4:11, 17-18. In fact, after the Background section, the ‘024 patent
`
`only mentions a “computer” once. Id., 4:61-62 (“One or more embodiments of the
`
`invention comprise a system executing with a computer.”). Thus, according to the
`
`applicant, it is not any particular software or hardware configurations, i.e. the
`
`technological features, that are key to the claimed subject matter. Rather, it is
`
`merely the recited functionality for determining conformity with regulatory
`
`conditions that is allegedly novel over the prior art. As the Board previously
`
`recognized in its Decision to Institute in CBM2012-00001, where a patent states
`
`that the claimed invention “may be implemented in any type of computer system or
`
`programming or processing environment . . . [the claim] lacks a novel and
`
`unobvious technical feature.” Exh. 1004, at 27-28.
`
`
`
`11
`
`DOCSLA#112133
`
`
`
`
`
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`The prosecution history demonstrates that any allegedly novel and
`
`unobvious features of the inventions claimed in the ‘024 patent pertain to
`
`computing compensation for sales representatives that conform to a set of
`
`regulatory conditions, not the use of a technological feature to accomplish this
`
`task. During prosecution, the applicant repeatedly attempted to distinguish prior
`
`art based on the fact that the claimed invention involves determining sales
`
`representatives’ conformity with regulatory conditions and computing
`
`compensation based on sales representatives’ conformity with those regulatory
`
`conditions. In total, the applicant attempted to distinguish three pieces of prior art
`
`based on the fact that the “determining” and “computing” steps required sales
`
`representatives’ conformity with a set of regulatory conditions in order to receive
`
`compensation. Exh. 1002, 7/9/2008 37 C.F.R. § 1.114 RCE Submission, at 11-14
`
`(arguing that Carrott does not teach or suggest the “determining” and “computing”
`
`steps); 8/7/2009 Response to Notice of Non-Compliant Amendment, at 14-15
`
`(arguing that Carrott in view of Lederer does not teach or suggest the
`
`“determining” and “computing” steps); 4/26/2010 Response to Final Office
`
`Action, at 11-16 (same); 5/24/2010 37 C.F.R. § 1.114 RCE Submission, at 11-15
`
`(same); and 10/22/2010 Response to Non-Final Office Action, at 11-15 (same).
`
`The applicant’s 10/22/2010 Response to Non-Final Office Action is exemplary:
`
`
`
`12
`
`DOCSLA#112133
`
`
`
`
`
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`Carrott in view of Lederer neither teaches nor suggests
`“determin[ing] if said sales representatives associated with said
`transaction data are in conformity with a set of regulatory
`conditions applicable to said sales” and “comput[ing] a
`plurality of compensation amounts based on said sale
`transactions data and said set of regulatory conditions.
`
`Exh. 1002, 10/22/2010 Response to Non-Final Office Action, at 11 (alterations in
`
`original). Thus, the applicant confirmed that any allegedly novel and unobvious
`
`features of the claimed subject matter are non-technological.
`
`ii.
`
`The ‘024 Patent Does Not Address a Technical
`Problem, Nor Does It Provide a Technical Solution
`
`The claimed subject matter also does not solve a technical problem with a
`
`technical solution. In the Background section of the ‘024 patent, the applicant
`
`describes a problem in the prior art as relating to “[c]redential management [that] is
`
`a critical issue for many firms.” Exh. 1001, 3:24. The applicant further describes
`
`that firms need to keep up with changing governmental rules and regulations, and
`
`track professional accreditation in light of sales representatives that may be hired,
`
`move, or quit. Id., 3:25-43. During prosecution the applicant characterized the
`
`problem in a similar fashion: “The Present Application identifies a problem with
`
`conventional systems and a need to, for example, manage sales compensation in a
`
`regulatory environment that places regulatory conditions on sales.” Exh. 1002,
`
`
`
`13
`
`DOCSLA#112133
`
`
`
`
`
`10/19/2007 Response to Non-Final Office Action, at 12. The applicant also
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`contrasted the problems addressed by the prior art (compliance of sales
`
`transactions) with the problem addressed by the claims (compliance of distributors
`
`or sales agents):
`
`Furthermore, Lederer is not even directed towards a sales
`representative. Lederer specifically teaches that “The invention
`is directed to a system 100 for use in ensuring compliance with
`regulations regarding the shipment of products between
`multiple regions and/or the handling/use of products within the
`regions.” Lederer, para. 0038. Thus, Lederer is directed
`towards ensuring compliance with regulations of products and
`not with “sales representatives” conformity with regulatory
`conditions. [Issued claim 1] recites “determining if said sales
`representatives associated with said transaction data are in
`conformity with a set of regulatory conditions applicable to said
`sales.” “Products” can be the subject of a sale. Clearly, “sales
`representatives” are not the subject of a sale.
`
`Accordingly, Lederer is addressing a different problem.
`
`Exh. 1002, 4/26/2010 Response to Final Office Action, at 15. Ensuring a sales
`
`representative’s compliance with regulatory conditions is not a technical problem.
`
`Moreover, the applicant does not teach or suggest a technological solution.
`
`In the prosecution history, the applicant described the solution provided by the
`
`
`
`14
`
`DOCSLA#112133
`
`
`
`
`
`claims as a “link” between regulations and the computation of compensation
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`amounts:
`
`Since Carrott did not teach or suggest a solution or even a link
`between any rules or regulations and commission payments, a
`question arises as to whether Lederer teaches such a solution or
`link. As explained below, Applicants respectfully submit that
`Carrott in view of Lederer neither teaches nor suggests
`“determin[ing] if said sales representatives associated with said
`transaction data are in conformity with a set of regulatory
`conditions applicable to said sales” and “comput[ing] a
`plurality of compensation amounts based on said sale
`transactions data and said set of regulatory conditions.”
`
`Exh. 1002, 4/26/2010 Response to Final Office Action, at 14 (alterations in
`
`original); see also id. at 12 (“Applicants respectfully submitted that the foregoing
`
`teachings [of Carrott] do not teach or suggest a link between any rules or
`
`regulations and commission payments.”). Thus, the “solution” proposed by the
`
`applicant was to determine whether sales representatives conform to a set of
`
`regulatory conditions when computing their compensation. The claimed subject
`
`matter does not recite any technological improvement in computer systems or
`
`processing nor does it tie the invention to any particular apparatus. The applicant
`
`concedes in the Background section that the use of software to manage distributers
`
`was known to be required in the prior art. Exh. 1001, 4:11-13 (“Computer
`
`
`
`15
`
`DOCSLA#112133
`
`
`
`
`
`software is necessary to implement the solution to these problems and fulfill the
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`perceived needs just described.” (emphasis added)). The claims recite no
`
`particular method to determine whether sales representatives conform to regulatory
`
`conditions. There is also no disclosure of a particular method to compute
`
`compensation amounts. Determining conformity with regulatory conditions during
`
`the process of computing compensation amounts, as opposed to merely before or
`
`after, is at best a workflow or management solution, not a technical solution,
`
`especially in light of the lack of technical features in the claims. In fact, the Board
`
`has previously held that “overcome[ing] the prior art’s disadvantages in storing,
`
`maintaining, and retrieving large amounts of data” does not solve a technical
`
`problem using a technical solution. Exh. 1004, at 23.
`
`Because claims 1, 2, and 35-47 of the ‘024 Patent neither recite a
`
`technological feature that is novel and unobvious over the prior art nor solve a
`
`technical problem with a technical solution, the ‘024 Patent claims are not directed
`
`to a “technological invention” and the ‘024 Patent is eligible for CBM review.
`
`
`
`16
`
`DOCSLA#112133
`
`
`
` Petition for Covered Business Method Review
`U.S. Patent No. 7,958,024
`
`
`
`III